Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Average PT from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has received an average rating of "Buy" from the eighteen ratings firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, fourteen have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $24.88.

Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. upped their target price on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Friday, November 29th. Macquarie began coverage on Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective for the company. Barclays upped their target price on Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a research report on Friday, November 8th. KeyCorp initiated coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an "overweight" rating and a $23.00 price target for the company. Finally, Stephens reaffirmed an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently modified their holdings of PRVA. GAMMA Investing LLC lifted its stake in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after purchasing an additional 845 shares in the last quarter. First Horizon Advisors Inc. lifted its position in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after buying an additional 632 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in Privia Health Group during the fourth quarter worth $51,000. Quarry LP grew its holdings in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. Finally, KBC Group NV increased its stake in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company's stock worth $62,000 after acquiring an additional 871 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Price Performance

Privia Health Group stock traded up $0.21 during midday trading on Friday, reaching $23.38. The company's stock had a trading volume of 406,558 shares, compared to its average volume of 573,272. The stock has a market capitalization of $2.81 billion, a P/E ratio of 233.82, a PEG ratio of 3.09 and a beta of 0.87. The stock's 50-day simple moving average is $21.27 and its 200-day simple moving average is $20.02. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $23.62.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.